Developmental and oncogenic signalling
2021 SGR 01609
![Foto de Developmental and oncogenic signalling](/img/grupo.png)
![Foto de Hospital Universitario Virgen del Rocío](/img/noimage_org.png)
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (7)
2017
-
Multilayer OMIC Data in medullary thyroid carcinoma identifies the STAT3 pathway as a potential therapeutic target in RETM918T Tumors
Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1334-1345
2014
-
A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry
Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403
2013
-
Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions
American Journal of Pathology, Vol. 182, Núm. 2, pp. 350-362
-
Endometrial carcinoma: Molecular alterations involved in tumor development and progression
Oncogene, Vol. 32, Núm. 4, pp. 403-413
2012
-
Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: Role for proteins involved in resistance to apoptosis and hypoxia
Histopathology, Vol. 60, Núm. 3, pp. 460-471
-
The EMT signaling pathways in endometrial carcinoma
Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720
2011
-
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels
American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543